Background/Aims: PTPRT is an essential tumor suppressor that plays crucial roles in regulating the mechanisms of tumorigenesis. Polymorphisms in PTPRT have been reported associated with human longevity, but their association with the risk of esophageal squamous cell carcinoma (ESCC) has not been found so far. In this study, we focused on the miRNAs associated SNPs in the 3'-UTR of PTPRT to investigate the further relationship of the SNPs with miRNAs among Chinese ESCC patients. Methods: We performed case-control study including 790 ESCC patients and 749 cancer-free controls. Genotyping, real time PCR assay, cell transfection and the dual luciferase reporter assay were used in our study. Results: We found that patients suffering from smoking exposure, drinking exposure and the history of cancer indicated to be the susceptible population by comparing with controls. Besides, SNP rs2866943 in PTPRT 3'-UTR was involved in the occurrence of ESCC by acting as a protective factor while rs6029959 acting a risk factor. SNP rs2866943 was also could be regulated by miR-218 which caused a down-regulation of PTPRT in patients with CT and TT genotype. Furthermore, the carriers of CT and TT genotype presented a small tumor size as well as the low probability of metastasis. Conclusion: Our findings have shown that the SNP rs2866943 in PTPRT 3'-UTR, through disrupting the regulatory role of miR-218 in PTPRT expression, rs2866943 in PTPRT might act as a protective factor in the pathogenesis of ESCC.
Introduction
Esophageal carcinoma is one of the most deadly malignant tumors in the world. It has become the sixth leading cause of death and the eighth most frequently diagnosed cancer [1] . Esophageal carcinoma is divided into three types including squamous carcinoma (ESCC); adenocarcinoma and undifferentiated carcinoma based on pathological diagnosis [2] . ESCC is the most common subtype with a poor treatment and survive rate [3, 4] . Age, diet, genetic background and environmental factors are thought to be associated with risk of ESCC [5, 6] . Although many people are exposed to these risk factors, only a few individuals develop ESCC in their lifetimes, suggesting that genetic variation may contribute to esophageal carcinogenesis. Traditional treatment on ESCC including chemotherapy, radiation therapy and esophageal resection is not enough comparing with the increasing number of people suffering with ESCC [7] [8] [9] . Improving results with the candidate gene approach have led to its growing acceptance as a potentially useful method for investigating genetic risk factors for ESCC among Chinese.
Protein Tyrosine Phosphatase, Receptor type, T (PTPRO) is a member of the protein tyrosine phosphatase (PTP) family [10] . PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation [11] . This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracellular catalytic domains, and thus represents a receptor-type PTP. The extracellular region contains a meprin-A5 antigen-PTP (MAM) domain, Ig-like and fibronectin type III-like repeats [12] . Recently researchers have identified a heterozygous c.4094C-T transition in the PTPRT gene, resulting in a thr1365-tomet (T1365M) substitution at a highly conserved residue in the second tyrosine phosphatase catalytic domain which was highly associated with the pathogenesis of cancer [13, 14] . Wang et al. reported that the mutated tyrosine phosphatases are tumor suppressor genes, regulating cellular pathways that may be amenable to therapeutic intervention [15] .
MiRNAs are small, non-coding RNA molecules of 19-25 nucleotides which have been reported to play important roles by regulating cell differentiation, proliferation, migration and apoptosis [16] . MiRNAs negatively regulate their target genes expression at the posttranscription level through binding to 3' untranslated regions (UTRs) of their targets message RNAs [17, 18] . miRNAs could also regulate the 3'UTR region who harboured the single-nucleotide polymorphisms (SNPs), SNP, as the most common human genetic variations, have been proved to be significantly related to the occurrence of diseases including gastric cancer [19] . More and more studies have provided evidences that SNPs located in the miRNA (miRSNPs) binding sites through affecting the binding of miRNAs with the target genes resulted in reduction or increase in the target mRNA translation, and thus being associated with the susceptibility to cancers [20, 21] . Researchers have found that the rs2910164 polymorphismin the sequence of miR-146a precursor may influence the susceptibility to gastric cancer in the Chinese population as well as SNPs rs4143815 and rs4819388 in the 3'UTRs of B7-H1 and B7-H2 genes were significantly related to the occurrence of gastric cancer [22] [23] [24] .
In this study, we focused on the SNPs in the 3'UTR of PTPRT which has not been reported before. By using the bioinformatics software (http://www.bioguo.org/miRNASNP/), we obtained all the SNPs which could regulate by different miRNAs as candidate SNPs and further investigated the allele distribution in a case-control study.
Materials and Methods

Study subjects
The hospital-based case-control study consists of 790 patients newly diagnosed with ESCC and 749 cancer-free controls. All the subjects were genetically unrelated Han Chinese recruited from the the People' 
Genotype
We extracted genomic DNA from peripheral whole blood of every validation subject by using QIAamp DNA blood mini kits (Qiagen, Germany) according to the manufacturer's instructions. Genotyping was performed with the TaqMan SNP Genotyping Assay. The PCR reactions were carried out in a total volume of 5 μL containing TaqMan Universal Master Mix, 80X SNP Genotyping AssayMix, Dnase-free water and 10-ng genomic DNA. The PCR conditions were 2 min at 50°C, 10 min at 95°C, followed by 40 cycles at 95°C for 15 sec and 60°C for 1 min. The 384-well ABI 7900HT Real Time PCR System
Real time PCR assay
Real time polymerase chain reaction (RT-PCR) was performed to determine whether the C to T mutation changed the expression level of PTPRT. The amplification conditions were 95°C for 10 minutes, followed by 40cycles of 95°C for 30 seconds, 55°C for 40seconds, and 72°C for 30 seconds, and finally 4°C for 30 minutes for cooling.
Cell lines and cell culture
ESCC cell lines and TE-1 and Eca-109 were purchased from the Chinese Academy of Sciences Cell Bank. All cells were cultured in RPMI-1640 (Gibco, USA) supplemented with 10 % fetal bovine serum (Invitrogen, Carlsbad, USA) and grown in humidified 5 % CO2 at 37˚C. MiR-16 mimics and normal control were obtained from Genepharma (Shanghai, China).The transfection was conducted by using Lipofectamine 2000 (Invitrogen Corp, CA, USA).
Prediction of miRNAs binding to the SNP
Bioinformatics analysis (http://www.bioguo.org/miRNASNP/) was used to predict the related SNPs in the 3'UTR of PTPRT which could be regulated by different miRNAs.
Construction of luciferase-based reporter plasmids
All the fragment of the 3'UTR containing either C or T allele was amplified. The PCR production was cloned into the pGL3-promoterless luciferase-based plasmid (Promega, CA, USA) at the cloning site between KpnI and XhoI. The amplified fragment was verified by DNA sequencing.
Dual-luciferase reporter assay
The 3'-UTR sequence of PTPRT predicted to interact with miR-218 or a mutated sequence with the predicted target sites were inserted into the KpnI and XhoI sites of pGL3 promoter vector (Genscript, Nanjing, China). For reporter assay, cells were plated onto 24-well plates and transfected with 100 ng of pGL3-PTPRT wild, pGL3-PTPRT mutant and miR-218 mimics, respectively by using Lipofectamine 2000 (Invitrogen Corp, CA, USA). A Renilla luciferase vector pRL-SV40 (5 ng) was also co-transfected to normalize the differences in transfection efficiency. Transfection was repeated three times in triplicate
Statistical analysis
The association between rs2866943 and rs6029959 genotypes and the risk of ESCC was evaluated by calculating the odds ratios (ORs) and their 95% confidence intervals (CIs) using univariate and multivariate logistic regression analysis. Stratification analysis was performed according to the clinical characteristic and risk classification to determine the genotype distribution in cases and controls as well as their association with the risk of ESCC. The difference of the expression levels of PTPRT with three genotypes and the difference of the relative luciferase activities between the wild and mutant genotype were evaluated by independent-sample t test. All statistical tests were two-sided and P< 0.05 was considered statistically significant. Statistical analysis was performed with SPSS 13.0 (SPSS Ltd.) and SAS software (version 9.1.3; SAS Institute, Cary, NC, USA). The graphs were generated by Graphpad Prism 5.0 (Graphpad Software, Inc.).
Results
Subject characteristics
The characteristics of the 790 ESCC patients and 749 healthy controls are summarized in Table 1 . No statistically significant differences were observed between cases and controls in terms of sex and age (both P>0.05). Patients suffering from smoking exposure, drinking exposure and the history of cancer indicated to be the susceptible population by comparing with controls.
The miRSNPs in the PTPRT gene 3'-UTR
In order to investigate the miRNA associated SNPs in the 3'UTR of PTPRT, we first found all the SNPs from the SNP databases NCBI db SNP BUILED 129 and ENSEMBL v58 in the 3'-UTR of PTPRT gene with the minor allele frequency(MAF)>0.05. We then used bioinformatic softwares Diana-Micro, MicroInspector, miR-anda, miRNAMap, RNAhybrid to predict miRNAs that can bind to the PTPRT 3'-UTR. The miRNASNP database was also applied to explore the miRNAs which could also bind to the 3'-UTR of patients harbored the SNP. As shown in Table 2 . Finally, we obtained 23 SNPs in the 3'UTR which could be regulated by different miRNAs. The positions of the SNPs in PTPRT as well as the variants were listed. Further genotyping was performed to detect the distribution of allele gene of the 23 SNPs in our research.
Correlation of rs2866943 and rs6029959 with gastric cancer
We detected all the 23 SNPs genotype frequencies in 790 ESCC cases and 749 controls. Only two SNPs (rs2866943 and rs6029959) indicated a significant difference in ESCC patients with the T-allele carriers and C-allele carrier, respectively; however, the other SNPs presented no difference (data not shown). As listed in Table3, Chi-square statistical analysis results showed that the genotypes of rs2866943 were in Hardy-Weinberg equilibrium distribution pattern in the healthy control group (P = 0.42). Further, logistic regression analysis results revealed that The CT genotype and TT genotype presented a significant dereased risk of ESCC 
The effect of rs2866943 and rs6029959 on the regulatory role of miRNAs in PTPRT expression
Since the SNP rs2866943 and rs6029959 were predicted to locate in the binding site of miR-218 and miR-142-5p, respectively. We hypothesized that the expression of PTPRT might be regulated by these miRNAs, which can be impacted Table 2 . SNPs located in the PTPRT gene 3'-UTR and the predicted miRNAs. Chr = chromosome; UTR= Untranslated Regions by rs2866943 or rs6029959. To test whether or not the inhibitory role of these miRNAs impacted by the two SNPs, we first detected the expression level of PTPRT expression level in patients harbored the CC, CT and TT genotypes as well as the patients with AA, AC and CC genotypes. We found that patients with CT or TT genotypes presented a decreased level of PTPRT by comparing with the patients with CC genotype; however there was no difference in rs6029959 (Fig. 1A and 2A) . We then constructed pGL3 vectors including the allelespecific binding sequences, and then co-transfected it with miR-218 or miR-142-5p as well as the controls in ESCC cell lines including TE-1 and Eca109 (Fig. 1B and 2B ). As presented in Figure1C, D and 2C, D, we found that the expression of T-allele-specific pGL3 construct was significantly suppressed by miR-218 (P = 0.003). However, the expression of C-allele-specific pGL3 construct was not inhibited by miR-142-5p (P = 0.324). These findings suggested that the inhibitory affection of the TT or CT genotype of PTPRT might be regulated by miR-218.
Stratified analyses of association between PTPRT polymorphism and ESCC risk
Then, we did stratified analysis of the association of the rs2866943 genotypes with the clinicopathological parameters of ESCC (Table 4) . We found a significant association of the
rs2866943 genotypes with the tumor size, and tumor metastasis,. Compared with the CC homozygote, the carriers of CT and TT genotype presented a small tumor size as well as the low probability of metastasis.
Discussion
In the present study, we investigated the relationship between miRSNPs within the 3'-UTR of PTPRT gene and the risk of ESCC. We observed that PTPRT rs2866943 CT or TT genotype is associated with significantly decreased ESCC risk compared with CC genotype and the increased risk of CC and AC genotypes comparing with AA genotype of SNP rs6029959. 
Cellular Physiology and Biochemistry
Protein tyrosine phosphatases (PTPs) are known to be signaling molecules that regulate a variety of cellular processes including differentiation, cell proliferation, mitotic cycle and oncogenic transformation [25] . Emerging evidence has revealed that mutations in PTPs play vital roles in tumorigenesis [26] . PTPRT, also known as PTPρ, is a member of the PTPs family. Recently, it has been reported that PTPRT is the most frequently mutated PTP gene in colorectal cancers (CRCs). PTPRT normally acts as a tumor suppressor and over-expression of PTPRT inhibits CRC cell growth [15] . It has been also reported that PTPRT knockout mice are highly susceptible to carcinogen azoxymethane-induced colon tumor [15] . Considering about the tumor suppressor gene function of PTPRT, our founding indicated that the C>T SNP might be acted as protective factor in the pathogenesis of ESCC, however, the CT and TT genotypes could be down-regulated by miR-218. Numerous microRNAs have been reported to be associated in cancers; however, the consequence of miRNA deregulation in cancer is still unknown for many miRNAs [27] . As for the miRNAs focused in this study, miR-218 expression was found to be increased in multiple cancers. Increased miR-218 was associated with tumor growth and metastasis which was consistent with our results [28, 29] .
In summary, we reported the first evidence that the SNP rs2866943 in PTPRT 3'-UTR was involved in the occurrence of ESCC by acting as a protective factor while rs6029959 acting a risk factor. SNP rs2866943 was also could be regulated by miR-218 which caused a down-regulation of PTPRT in patients with CT and TT genotype. This SNP was also found to be related to the clinicopathological features of ESCC, suggesting it may have important roles in preventing tumor development. Our results support the hypothesis that genetic variants interrupting miRNAs mediated regulation tumor suppressors would be involved in esophageal cancer etiology.
